Up a level |
Journal Article
Sinner, Friedrich ORCID: 0000-0003-0524-8833, Pinter, Matthias ORCID: 0000-0002-7260-532X, Scheiner, Bernhard ORCID: 0000-0002-4904-5133, Ettrich, Thomas Jens, Sturm, Niklas ORCID: 0000-0001-9219-0099, Gonzalez-Carmona, Maria A., Waidmann, Oliver, Finkelmeier, Fabian ORCID: 0000-0001-8559-9910, Himmelsbach, Vera, De Toni, Enrico N., Ben Khaled, Najib, Mohr, Raphael ORCID: 0000-0003-2403-4275, Fruendt, Thorben Wilhelm, Kuetting, Fabian, van Boemmel, Florian, Lieb, Sabine, Krug, Sebastian ORCID: 0000-0003-1672-7995, Bettinger, Dominik ORCID: 0000-0002-8782-8729, Schultheiss, Michael, Jochheim, Leonie S., Best, Jan, Mueller, Christian ORCID: 0000-0002-6881-1817, Keitel, Verena and Venerito, Marino ORCID: 0000-0001-8581-0974 (2022). Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers, 14 (23). BASEL: MDPI. ISSN 2072-6694
Scheiner, Bernhard ORCID: 0000-0002-4904-5133, Pomej, Katharina ORCID: 0000-0002-2807-3565, Kirstein, Martha M., Hucke, Florian ORCID: 0000-0001-7887-3440, Finkelmeier, Fabian, Waidmann, Oliver, Himmelsbach, Vera, Schulze, Kornelius, von Felden, Johann ORCID: 0000-0003-2839-5174, Frundt, Thorben W., Stadler, Marc, Heinzl, Harald, Shmanko, Kateryna, Spahn, Stephan, Radu, Pompilia, Siebenhuener, Alexander R., Mertens, Joachim C., Rahbari, Nuh N., Kuetting, Fabian, Waldschmidt, Dirk-Thomas, Ebert, Matthias P., Teufel, Andreas, De Dosso, Sara, Pinato, David J., Pressiani, Tiziana ORCID: 0000-0001-6919-1536, Meischl, Tobias, Balcar, Lorenz ORCID: 0000-0002-6708-3061, Mueller, Christian, Mandorfer, Mattias, Reiberger, Thomas ORCID: 0000-0002-4590-3583, Trauner, Michael ORCID: 0000-0002-1275-6425, Personeni, Nicola ORCID: 0000-0002-7995-272X, Rimassa, Lorenza ORCID: 0000-0001-9957-3615, Bitzer, Michael ORCID: 0000-0002-4463-8263, Trojan, Joerg, Weinmann, Arndt, Wege, Henning, Dufour, Jean-Francois, Peck-Radosavljevic, Markus, Vogel, Arndt and Pinter, Matthias (2022). Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. J. Hepatol., 76 (2). S. 353 - 365. AMSTERDAM: ELSEVIER. ISSN 1600-0641